Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Arrow Financial ( (AROW) ) has shared an announcement.
Arrow Financial Corporation reported a net income of $6.3 million for the first quarter of 2025, an increase from $4.5 million in the previous quarter, with earnings per share rising to $0.38. The company declared a quarterly cash dividend of $0.28 per share and authorized a $5 million increase in its share repurchase program. Despite a $3.75 million reserve related to a commercial real estate loan, Arrow’s core profitability improved, supported by strong margin expansion and loan growth. The company is progressing with its strategic initiatives, including expanding its Corporate Banking Team and finalizing the unification of its banking subsidiaries.
Spark’s Take on AROW Stock
According to Spark, TipRanks’ AI Analyst, AROW is a Neutral.
Arrow Financial’s overall stock score reflects robust revenue growth and a strong balance sheet with no debt, though declining ROE and cash flow issues are concerns. The technical analysis suggests caution due to bearish trends, while valuation metrics are supportive of the stock’s attractiveness. Recent corporate events highlight positive developments, such as stock buybacks and operational improvements, which add to the stock’s appeal.
To see Spark’s full report on AROW stock, click here.
More about Arrow Financial
Arrow Financial Corporation operates in the financial services industry, primarily focusing on banking services. The company is known for its corporate banking and loan services, with a market focus on the Capital Region of New York State.
YTD Price Performance: -13.66%
Average Trading Volume: 43,293
Technical Sentiment Signal: Hold
Current Market Cap: $408.9M
See more data about AROW stock on TipRanks’ Stock Analysis page.